Northwestern investigators have formed an interdisciplinary group to address the global issue of antimicrobial resistance.
Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
Therapeutically inhibiting a metabolic regulator in monocytes unexpectedly increased inflammatory signaling, revealing mechanisms that could inform new strategies to treat chronic inflammatory disorders, according to a recent study.
Northwestern Medicine investigators continue to study COVID-19, from comparing mortality rates between SARS-CoV-2 variants to examining the effectiveness of maternal vaccination in protecting infants and combating COVID-19 misinformation on social media.
Northwestern Medicine scientists are expanding the global network of COVID-19 sequencing in regions where there is limited viral genetic information reporting.
The membrane-bound form of the ACE2 protein is the essential receptor for enabling COVID-19 infectivity, according to a Northwestern Medicine study.
New advances in CRISPR gene-editing technology may lead to longer-lasting treatments and new therapeutic strategies for HIV/AIDS.
Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
A new publication outlines the structure-function relationships between the first spherical nucleic acid vaccine developed to protect against viral infections, including COVID-19.